In MSI CRC, CDKN1A upregulation suggests enhanced checkpoint fidelity and stronger p53-dependent growth arrest, which may allow tumor cells to repair DNA damage induced by 5-FU, potentially contributing to relative chemoresistance [84]. Here, CDKN1A is linked to neoplasm.